Temporally controlled targeted somatic mutagenesis in skeletal muscles of the mouse.

Date publication

avril 2005

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CHAMBON Pierre , Dr METZGER Daniel

Tous les auteurs :
Schuler M, Ali F, Metzger E, Chambon P, Metzger D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/15789425

Résumé

To generate temporally controlled targeted somatic mutations selectively and efficiently in skeletal muscles, we established a transgenic HSA-Cre-ER(T2) mouse line in which the expression of the tamoxifen-dependent Cre-ER(T2) recombinase is under the control of a large genomic DNA segment of the human skeletal muscle alpha-actin gene, contained in a P1-derived artificial chromosome. In this transgenic line Cre-ER(T2) is selectively expressed in skeletal muscles, and Cre-ER(T2)-mediated alteration of LoxP flanked (floxed) target genes is skeletal muscle-specific and strictly tamoxifen-dependent. HSA-Cre-ER(T2) mice should be of great value to analyze gene function in skeletal muscles, and to establish animal models of human skeletal muscle disorders.

Référence

Genesis. 2005 Apr;41(4):165-70.